Vaccine stocks continue to explode higher.
Moderna (MRNA) has now from $72 to $172, as it nears its meeting with the US FDA on Dec. 17 with regards to emergency use authorization.

BioNTech (BNTX) has run from $90 to $130 a share, as it also nears emergency use authorization with the US FDA. Even Pfizer (PFE) has run from $35 to $43. We’d like to see the PFE stock closer to $50 a share if the US FDA grants emergency use.
With the virus still out of control, all three of these stocks are still buy opportunities.
The opportunities we find quite often inside Extreme Option Profits.

EARN 58% & MORE Per Trade On Average & Risk 91% LESS Doing It!
Potentially EARN 6,438% More Per Year By Defying All Of the Regular, Ordinary, Common, Boundaries & Restrictions On Trading & Investing (like our model portfolio)…
…With Speed, Convenience, & FREEDOM!…& Risk As Little As $300 & NEVER Own A Single Stock or ETF!